Meekoo Dhar
Overview
Explore the profile of Meekoo Dhar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keesari P, Samuels D, Vegivinti C, Pulakurthi Y, Kudithi R, Dhar M, et al.
Curr Hematol Malig Rep
. 2025 Jan;
20(1):3.
PMID: 39754658
Purpose Of Review: Multiple myeloma is a chronic malignancy and with evolving treatment options, understanding the economic burden and cost-effectiveness of therapies is crucial for clinicians and researchers. Recent Findings:...
2.
Jain A, Keesari P, Pulakurthi Y, Katamreddy R, Dhar M, Desai R
Pancreas
. 2024 Sep;
54(1):e51-e56.
PMID: 39324961
Objectives: Pancreatic cancer and prediabetes pose significant public health challenges. Given the lack of strong evidence we performed a meta-analysis to assess the risk of pancreatic cancer in prediabetes. Materials...
3.
Khan S, Araji G, Yetiskul E, Keesari P, Haddadin F, Khamis Z, et al.
World J Clin Oncol
. 2024 Jul;
15(6):730-744.
PMID: 38946836
The advancement of renal replacement therapy has significantly enhanced the survival rates of patients with end-stage renal disease (ESRD) over time. However, this prolonged survival has also been associated with...
4.
Waleed M, Dhulipalla L, Niazi M, Terjanian T, Dhar M
Cureus
. 2024 Apr;
16(3):e57252.
PMID: 38686279
Thrombotic thrombocytopenic purpura (TTP) is a rare disease that is part of a vast spectrum of thrombotic microangiopathies (TMAs). Despite the rarity of TTP, clinicians must maintain a high suspicion...
5.
Chukkalore D, Rajavel A, Asti D, Dhar M
Front Oncol
. 2023 Jul;
13:1188028.
PMID: 37465112
The incidence of endometrial cancer is increasing, however treatment options for advanced disease are limited. Hormonal therapy has demonstrated positive outcomes for Stage IV EC. Next generation sequencing (NGS) has...
6.
Seo G, Minkowitz J, Kapustin D, Fan J, Minkowitz G, Minkowitz M, et al.
Diagn Pathol
. 2023 Apr;
18(1):47.
PMID: 37072862
Background: Struma ovarii is an unusual ovarian teratoma containing predominantly thyroid tissue. Less than 10% of cases undergo malignant transformation in the thyroid tissue and are considered malignant struma ovarii...
7.
Castellanos M, Fanous E, Thaker R, Flory M, Seetharamu N, Dhar M, et al.
Pathol Res Pract
. 2023 Jan;
241:154298.
PMID: 36608623
Background: Lung cancer death remains the highest among all malignancies. Gender differences show women have an increased cancer incidence while men have worse outcomes. These observations identified that some lung...
8.
Hamadi R, Assaad M, Zurndorfer J, El Gharib K, Kwok R, Dhar M, et al.
Cureus
. 2022 Jul;
14(6):e25592.
PMID: 35795513
We present the case of a 73-year-old patient who was admitted to the neurocritical care unit with spontaneous intracerebral hemorrhage (ICH). Upon further investigation, she was found to have hyperleukocytosis...
9.
MacDougall K, Niazi M, Rehan M, Xue W, Dhar M
Cureus
. 2022 Mar;
14(2):e21912.
PMID: 35273861
Immunoglobulin D multiple myeloma (IgD MM) is a rare isotype of multiple myeloma (MM), comprising less than 2% of all cases. It is often associated with advanced disease at the...
10.
Droubi S, Aqsa A, Rehan M, Dhar M
Chemotherapy
. 2021 Feb;
:1-3.
PMID: 33540405
Palbociclib is a cyclin-dependent kinase (CDK) 4/6 inhibitor. Palbociclib combined with endocrine therapy has shown promising results in hormone-receptor-positive (HR+) and human epidermal growth factor receptor-negative (HER-2-) breast cancer progression....